Market Research Logo

North America Computed Tomography (CT) Systems Market Outlook to 2022

North America Computed Tomography (CT) Systems Market Outlook to 2022

Summary

GlobalData’s new report, North America Computed Tomography (CT) Systems Market Outlook to 2022, provides key market data on the North America Computed Tomography (CT) Systems market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and 16-slice and below CT Systems.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Computed Tomography (CT) Systems market segements - 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and 16-slice and below CT Systems.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for each of the market segements.
  • Global corporate-level profiles of key companies operating within the North America Computed Tomography (CT) Systems market.
  • Key players covered include Siemens Limited, GE Healthcare Limited, Toshiba Medical Systems Corporation and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Computed Tomography (CT) Systems Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Computed Tomography (CT) Systems Market, North America
3.1 Computed Tomography (CT) Systems Market, North America, Revenue ($m), 2008-2022
3.2 Computed Tomography (CT) Systems Market, North America, Revenue ($m), 2008-2015
3.3 Computed Tomography (CT) Systems Market, North America, Revenue ($m), 2015-2022
3.4 Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2022
3.5 Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2015
3.6 Computed Tomography (CT) Systems Market, North America, Volume (Units), 2015-2022
3.7 Computed Tomography (CT) Systems Market, North America, Company Share by Revenue ($m), 2015
4 Computed Tomography (CT) Systems Market, Canada
4.1 Computed Tomography (CT) Systems Market, Canada, Revenue ($m), 2008-2015
4.2 Computed Tomography (CT) Systems Market, Canada, Revenue ($m), 2015-2022
4.3 Computed Tomography (CT) Systems Market, Canada, Volume (Units), 2008-2015
4.4 Computed Tomography (CT) Systems Market, Canada, Volume (Units), 2015-2022
4.5 Computed Tomography (CT) Systems Market, Canada, Average Price ($), 2008-2022
4.6 Computed Tomography (CT) Systems Market, Canada, Distribution Share by Revenue ($m), 2014-2015
4.7 Computed Tomography (CT) Systems Market, Canada, Company Share by Revenue ($m), 2015
5 Computed Tomography (CT) Systems Market, Mexico
5.1 Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), 2008-2015
5.2 Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), 2015-2022
5.3 Computed Tomography (CT) Systems Market, Mexico, Volume (Units), 2008-2015
5.4 Computed Tomography (CT) Systems Market, Mexico, Volume (Units), 2015-2022
5.5 Computed Tomography (CT) Systems Market, Mexico, Average Price ($), 2008-2022
5.6 Computed Tomography (CT) Systems Market, Mexico, Distribution Share by Revenue ($m), 2014-2015
5.7 Computed Tomography (CT) Systems Market, Mexico, Company Share by Revenue ($m), 2015
6 Computed Tomography (CT) Systems Market, United States
6.1 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2008-2015
6.2 Computed Tomography (CT) Systems Market, United States, Revenue ($m), 2015-2022
6.3 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2008-2015
6.4 Computed Tomography (CT) Systems Market, United States, Volume (Units), 2015-2022
6.5 Computed Tomography (CT) Systems Market, United States, Average Price ($), 2008-2022
6.6 Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), 2014-2015
6.7 Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), 2015
7 Overview of Key Companies in North America Computed Tomography (CT) Systems Market
7.1 Siemens Limited
7.1.1 Company Overview
7.2 GE Healthcare Ltd
7.2.1 Company Overview
7.3 Toshiba Medical Systems Corporation
7.3.1 Company Overview
7.4 Philips Healthcare
7.4.1 Company Overview
8 Computed Tomography (CT) Systems Market Pipeline Products
9 Recent Developments
9.1 Corporate Communications
9.1.1 Dec 19, 2016: OPKO Health to be Added to the NASDAQ Biotechnology Index
9.1.2 Dec 12, 2016: VIDA Diagnostics names new COO
9.1.3 Nov 22, 2016: USC Roski Eye Institute conducted patient trials for breakthrough refractory glaucoma treatment
9.1.4 Nov 22, 2016: Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma Gene Expression Classifier in 2017
9.1.5 Oct 24, 2016: Analogic Announces Leadership Transition
9.1.6 Sep 27, 2016: Camargo Pharmaceutical Services Adds to Medical Device Expertise
9.1.7 Sep 13, 2016: OPKO Health Appoints Jane Pine Wood as Chief Legal and Compliance Officer of BioReference Laboratories
9.1.8 Sep 08, 2016: iCAD Announces Management Transition
9.1.9 Sep 06, 2016: GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort Turbohaler in COPD at ERS International Congress
9.1.10 Sep 01, 2016: NeuroMetrix Announces Issuance of Patent for DPNCheck Core Technology in China
9.1.11 Aug 31, 2016: Bruce Elder Named CEO of MedQuest
9.1.12 Aug 10, 2016: Camargo Pharmaceutical Services Grows, Adds Three Drug Development Experts
9.1.13 Jul 07, 2016: Two SwedishAmerican Physician Executives Assume New Positions
9.1.14 Jun 13, 2016: OPKO Health Announces Move to NASDAQ Stock Market
9.1.15 May 25, 2016: ProLungdx Board Names Dr. John C. Ruckdeschel as Newest Board Member
9.1.16 May 11, 2016: Regeneron and Sanofi Genzyme to Present Additional Data from Pivotal Phase 2b Dupilumab Study in Adults with Uncontrolled Persistent Asthma at the American Thoracic Society International Conference
9.1.17 May 10, 2016: Cerulean Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRLX101 in Combination with LYNPARZA
9.1.18 Apr 21, 2016: RefleXion Medical Strengthens Management Team to Bring Biology-Guided Radiotherapy Into the Clinic
9.1.19 Feb 25, 2016: Algobate Announces Positive Pre-Phase 3 Meeting With FDA for Naloxone PRT in Opioid Induced Constipation
9.1.20 Feb 22, 2016: IMRIS, Deerfield Imaging Board of Directors Appoints Andrew M. Flanagan as Chief Executive Officer
9.1.21 Feb 17, 2016: Alliance HealthCare Services Announces Rhonda Longmore-Grund to Assume Chief Financial Officer Role as Part of Planned Transition
9.1.22 Feb 08, 2016: Timothy Damadian Named President and CEO of FONAR
9.1.23 Jan 26, 2016: Bernard Bailey Appointed Chairman and Steve Odland Joins Analogic’s Board
9.2 Financial Announcements
9.2.1 Jan 10, 2017: Stryker provides 2016 preliminary net sales results
9.2.2 Dec 06, 2016: Analogic Announces Results for the First Quarter ended October 31, 2016 and Declares Quarterly Cash Dividend
9.2.3 Nov 29, 2016: Imaging Dynamics Q3 net loss increases
9.2.4 Nov 09, 2016: FONAR Announces 1st Quarter Financial Results For Fiscal 2017
9.2.5 Nov 07, 2016: OPKO Health Reports Third Quarter Financial and Operating Results
9.2.6 Nov 03, 2016: Alliance HealthCare Services Reports Results for the Third Quarter Ended September 30, 2016
9.2.7 Nov 02, 2016: iCAD Reports Third Quarter 2016 Financial Results
9.2.8 Oct 27, 2016: Stryker reports third quarter 2016 results
9.2.9 Oct 27, 2016: Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance
9.2.10 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
9.2.11 Sep 21, 2016: Analogic Announces Results for the Fourth Quarter and Fiscal Year Ended July 31, 2016 and Declares Quarterly Cash Dividend
9.2.12 Sep 19, 2016: FONAR Announces Fiscal 2016 Year End Earnings
9.2.13 Aug 17, 2016: Accuray Reports Fourth Quarter and Fiscal 2016 Financial Results
9.2.14 Aug 08, 2016: OPKO Health Reports Improved Financial and Operating Results
9.2.15 Aug 04, 2016: Alliance HealthCare Services Reports Results for the Second Quarter and Six Months Ended June 30, 2016
9.2.16 Jul 27, 2016: iCAD Reports Second Quarter 2016 Financial Results
9.2.17 Jul 25, 2016: Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Trial With KEYTRUDA
9.2.18 Jul 25, 2016: VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate
9.2.19 Jul 21, 2016: Stryker reports second quarter 2016 results
9.2.20 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
9.2.21 Jun 01, 2016: Analogic Announces Results for the Third Quarter Ended April 30, 2016 and Declares Quarterly Cash Dividend
9.2.22 May 10, 2016: FONAR Announces 3rd Quarter and Nine Months Financial Results for Fiscal 2016
9.2.23 May 09, 2016: OPKO Health Reports First Quarter Financial and Operating Results
9.2.24 May 05, 2016: Alliance HealthCare Services Reports Results for the First Quarter Ended March 31, 2016
9.2.25 May 03, 2016: ICAD Reports First Quarter 2016 Financial Results
9.2.26 Mar 10, 2016: Alliance HealthCare Services Reports Fourth Quarter & Full Year 2015 Results
9.2.27 Mar 02, 2016: Analogic Announces Results for the Second Quarter Ended January 31, 2016 and Declares Quarterly Cash Dividend
9.2.28 Mar 01, 2016: iCAD Reports Fourth Quarter and Full Year 2015 Financial Results
9.2.29 Feb 09, 2016: FONAR Announces Fiscal 2016 2nd Quarter and Six Months Financial Results
9.3 Government and Public Interest
9.3.1 Jun 05, 2016: LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer
9.3.2 May 23, 2016: Teijin Pharma’s Feburic (Febuxostat) Approved as Indication for Cancer Chemotherapy-Induced Hyperuricemia
9.3.3 May 22, 2016: Data from New Analyses of Studies with Veltassa Presented at 53rd European Renal Association Congress
9.3.4 Apr 25, 2016: GlycoMimetics Data on GMI-1271 Treatment of Acetaminophen-Triggered Liver Toxicity to Be Presented at Digestive Disease Week Conference
9.3.5 Apr 13, 2016: Bio Products Laboratory Announces FDA Submission of Biologics License Supplement for Gammaplex 10%
9.3.6 Mar 01, 2016: Nordic Nanovector: Late-Breaking Abstract on Betalutin Phase 1/2 Study Accepted for Presentation at American Association for Cancer Research Annual Meeting 2016
9.3.7 Jan 28, 2016: European Commission Approves Daklinza (daclatasvir) for the Treatment of Genotype 1, 3 and 4 Chronic Hepatitis C Patients with HIV Coinfection, Advanced Cirrhosis and Post-liver Transplant Recurrence of HCV
9.4 Legal And Regulatory
9.4.1 Aug 15, 2016: Med Center Health Facilities Earn ACR Lung Cancer Screening Center Designation
9.5 Other Significant Developments
9.5.1 Jul 31, 2016: Toshiba and AHRA Open Applications for Ninth Annual Putting Patients First Program
9.5.2 Jun 21, 2016: iCAD Commends Final USPSTF Recommendations for Colorectal Cancer Screening Including Computed Tomography Colonography
9.5.3 Jun 09, 2016: NeuroMetrix Showcases Quell Technology at SLEEP 2016, the 30th Anniversary Meeting of the Associated Professional Sleep Societies
9.5.4 May 12, 2016: IMRIS, Deerfield Imaging Announces New Department - Office of the Customer
9.5.5 Apr 01, 2016: BTG announces US launch of LC Bead LUMI, ground-breaking radiopaque embolic bead
9.5.6 Mar 22, 2016: The University of Tennessee College of Medicine Launches the World’s First Mobile Stroke Unit with Advanced CT Imaging Capabilities Including CT Angiography Imaging for the Brain and Blood Vessels
9.6 Product News
9.6.1 Dec 19, 2016: Algorithm provides an extra level of assurance during spine surgery
9.6.2 Sep 14, 2016: Fluxion Biosciences Launches IsoFlux Cytation Imager for Automated CTC Analysis
9.6.3 Sep 07, 2016: Bruker Unveils Next-Generation Preclinical Imaging Systems for Advanced Translational Research at World Molecular Imaging Congress
9.6.4 Sep 06, 2016: Advanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and Cardio-Oncology Indications at University of Ottawa Heart Institute and Ottawa Hospital
9.6.5 Jun 08, 2016: NICE draft recommendation on the use of aflibercept (EYLEA) for management of branch retinal vein occlusion goes against Royal College of Ophthalmologists’ guidance
9.6.6 Apr 26, 2016: Philips receives FDA 510(k) clearance of CT imaging solutions for lung cancer screening to help hospitals of all sizes drive earlier detection and improve patient care decisions
9.7 Strategy And Business Planning
9.7.1 Nov 09, 2016: Keryx Biopharmaceuticals Announces U.S. FDA Approval of Second Contract Manufacturer for Auryxia (ferric citrate)
9.7.2 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation
9.7.3 Aug 09, 2016: Hitachi Medical Releases Major Upgrade to Oasis 1.2T Open MR
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Market Modeling and Forecasting
10.1.5 Company Share Analysis
10.1.6 Distribution Share Analysis
10.1.7 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
1.1 List of Tables
Table 1: Computed Tomography (CT) Systems Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022
Table 2: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015
Table 3: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022
Table 4: Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2022
Table 5: Computed Tomography (CT) Systems Market, North America, Volume (Units), Historic, 2008-2015
Table 6: Computed Tomography (CT) Systems Market, North America, Volume (Units), Forecast, 2015-2022
Table 7: Computed Tomography (CT) Systems Market, North America, Company Share by Revenue ($m), USD Constant, 2015
Table 8: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Table 9: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 10: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Historic, 2008-2015
Table 11: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Forecast, 2015-2022
Table 12: Computed Tomography (CT) Systems Market, Canada, Average Price ($), Historic, 2008-2015
Table 13: Computed Tomography (CT) Systems Market, Canada, Average Price ($), Forecast, 2015-2022
Table 14: Computed Tomography (CT) Systems Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 15: Computed Tomography (CT) Systems Market, Canada, Company Share by Revenue ($m), USD Constant, 2015
Table 16: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015
Table 17: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 18: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Historic, 2008-2015
Table 19: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Forecast, 2015-2022
Table 20: Computed Tomography (CT) Systems Market, Mexico, Average Price ($), Historic, 2008-2015
Table 21: Computed Tomography (CT) Systems Market, Mexico, Average Price ($), Forecast, 2015-2022
Table 22: Computed Tomography (CT) Systems Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 23: Computed Tomography (CT) Systems Market, Mexico, Company Share by Revenue ($m), USD Constant, 2015
Table 24: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Table 25: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 26: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015
Table 27: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022
Table 28: Computed Tomography (CT) Systems Market, United States, Average Price ($), Historic, 2008-2015
Table 29: Computed Tomography (CT) Systems Market, United States, Average Price ($), Forecast, 2015-2022
Table 30: Computed Tomography (CT) Systems Market, United States, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 31: Computed Tomography (CT) Systems Market, United States, Company Share by Revenue ($m), USD Constant, 2015
Table 32: Computed Tomography (CT) Systems Market Pipeline Products
1.2 List of Figures
Figure 1: Computed Tomography (CT) Systems Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2008-2022
Figure 2: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Historic, USD Constant, 2008-2015
Figure 3: Computed Tomography (CT) Systems Market, North America, Revenue ($m), Forecast, USD Constant, 2015-2022
Figure 4: Computed Tomography (CT) Systems Market, North America, Volume (Units), 2008-2022
Figure 5: Computed Tomography (CT) Systems Market, North America, Volume (Units), Historic, 2008-2015
Figure 6: Computed Tomography (CT) Systems Market, North America, Volume (Units), Forecast, 2015-2022
Figure 7: Computed Tomography (CT) Systems Market, North America, Company Share (%) 2015
Figure 8: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 9: Computed Tomography (CT) Systems Market, Canada, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 10: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Historic, 2008-2015
Figure 11: Computed Tomography (CT) Systems Market, Canada, Volume (Units), Forecast, 2015-2022
Figure 12: Computed Tomography (CT) Systems Market, Canada, Company Share (%) 2015
Figure 13: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 14: Computed Tomography (CT) Systems Market, Mexico, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 15: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Historic, 2008-2015
Figure 16: Computed Tomography (CT) Systems Market, Mexico, Volume (Units), Forecast, 2015-2022
Figure 17: Computed Tomography (CT) Systems Market, Mexico, Company Share (%) 2015
Figure 18: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 19: Computed Tomography (CT) Systems Market, United States, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 20: Computed Tomography (CT) Systems Market, United States, Volume (Units), Historic, 2008-2015
Figure 21: Computed Tomography (CT) Systems Market, United States, Volume (Units), Forecast, 2015-2022
Figure 22: Computed Tomography (CT) Systems Market, United States, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report